Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Oracle Investor Files Lawsuit Against $200 Mln Settlement With GSA

RELATED NEWS
Trade ORCL now with 

An investor of enterprise software giant Oracle Corp. (ORCL: Quote) has Thursday sued its directors over damages caused to the company related to its $200 million whistle-blower settlement with the U.S. government. Jordan Weinrib filed the lawsuit earlier in the day in a Delaware Chancery court.

Weinrib revealed in the complaint filed by him that the directors, including CEO Larry Ellison, failed in their fiduciary duties to shareholders by not mitigating losses created by the settlement. He is seeking an unspecified amount in damages on behalf of Oracle shareholders.

"Rather than attempt to settle all claims at that time by the institution of appropriate corporate therapeutics and the paying of what would have been a small fine, the board insisted on digging in and litigating the matter extensively," Weinrib said in the lawsuit.

In early October, Oracle agreed to pay $199.5 million plus interest to settle a whistle-blower lawsuit that was filed for failing to meet its contractual obligations to the General Services Administration or GSA.

The settlement resolves the lawsuit filed on behalf of the U.S. government by former Oracle employee, Paul Frascella, who will receive $40 million as his share of the recovery in the case. Later, the Department of Justice took up the case by joining the whistle-blower lawsuit in 2010.

The settlement, the largest ever obtained by the GSA under the False Claims Act, relates to a contract Oracle entered into in 1998 to sell software licenses and technical support to government entities through GSA's Multiple Award Schedule program.

Oracle allegedly failed to comply knowingly with the price reduction clause of its GSA contract by not disclosing to GSA discounts Oracle gave to its commercial customers when they were higher than the discounts that Oracle had disclosed to GSA. It failed to pass those discounts on to government customers.

The U.S. government alleged that it accepted lower discounts and ultimately paid far more than it should have for Oracle products because of those alleged fraudulent dealings.

"Despite substantial evidence of wrongdoing, Oracle's board of directors did not admit that these acts had occurred, enact remedial measures and negotiate a resolution that involved a small payment. Instead, by litigating the case, Oracle drove up the ultimate settlement price, harming taxpayers and shareholders alike," Weinrib added in the lawsuit.

ORCL closed Thursday's regular trading session at $28.63, down $0.78 or 2.65% on a volume of 59.76 million shares.

Register
To receive FREE breaking news email alerts for Oracle Corp. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
A ban on athletes using stamina-boosting gases - xenon and argon - came into effect on Monday. The World Anti-Doping Agency (WADA) said Hypoxia-Inducible Factor (HIF) activators Xenon and Argon have been added to the 2014 List of Prohibited Substances and Methods List following the required three-month notice period and UNESCO's communication to all States Parties. A recommendation to revise the British manufacturing growth eased further in August to its lowest level in 14 months as output and demand increased at slower rates, survey results from Markit Economics showed Monday. The Markit/CIPS Purchasing Managers' Index dropped to 52.5 from a revised 54.8 in July. Economists had expected the score to fall to 55.1 from July's original figure of 55.4. Consumers spent less in July than in the previous month, a surprise retreat that complicates the prevailing belief that the U.S. economic situation is improving. Along with the unexpected drop in spending, government figures released on Friday showed that incomes rose at a slower pace in July than in the previous month. Meanwhile, data on prices indicated that inflation pressures remain tame.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.